1. The person using Journal of Rheumatic Diseases may use, reproduce, disseminate, or display the open access version of content from this journal for non-commercial purposes.
2. ANY USE of the Open Access version of this Journal in whole or in part must include the customary bibliographic citation, including author and publisher attribution, date, article title, Journal of Rheumatic Diseases, and the URL https://www.jrd.or.kr and MUST include a copy of the copyright notice. If an original work is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.
3. For any commercial use of materials from the Open Access version of the journal, permission MUST be obtained from the Journal of Rheumatic Diseases (or Korean College of Rheumatology). E-mail: email@example.com
4. Commercial use is defined as being ANY kind of re-use for the commercial gain of the user, their employing institution and/or any other third party. Examples of commercial use include:
a. re-use by a non-author/third party/other publisher of parts of or all of an article or articles in another publication (journal or book) to be sold for commercial purposes
b. the proactive supply of multiple print or electronic copies of items taken from the Journal to third parties on a systematic basis for marketing purposes
c. re-use by an author of parts of or all of an article in other publications from commercial organizations
Ji-Hyoun Kang, M.D., Ph.D., Sung-Eun Choi, M.D., Dong-Jin Park, M.D., Ph.D., Shin-Seok Lee, M.D., Ph.D.J Rheum Dis 2022;29: 4-13
Chong Hyuk Chung, M.D.*, Gyuho Jang, M.D.*, Chang-Hoon Lee, M.D., Ph.D.J Rheum Dis 2021;28: 31-37
Hyoungyoung Kim, M.D., M.S., Yoon-Kyoung Sung, M.D., Ph.D., MPHJ Rheum Dis 2021;28: 60-67
Robert D Inman, M.D., FRCPC, FACP, FRCP EdinJ Rheum Dis 2021;28: 55-59